Search

Gene modifiers of cystic fibrosis lung disease: A systematic review Background: Lung disease is the major source of morbidity and mortality in cystic

Development and validation of a miniaturized bacteriophage host range screening assay against antibiotic resistant Pseudomonas aeruginosa

AREST CF has a detailed catalogue of our publications spanning back to 1996.

Predicting disease progression in cystic fibrosis ABSTRACT Introduction: Progressive lung disease is the major cause of morbidity and mortality in

Quantification of CT bronchiectasis and its relationship to ventilation in cystic fibrosis Editorial by Tim Rosenow

Create happy, healthy futures for generations of children

Discover resources and science activities for kids for the topic 'Power of Our Lungs'.

News & Events

Researchers from the Wal-yan Respiratory Research Centre are collaborating with Virex Pharma to undertake vital research into a potential breakthrough treatment for RSV infections in young children, thanks to a $499,241 grant awarded by the WA Department of Health Innovation Seed Fund.

News & Events

WA researchers will use a $1.97 million Medical Research Future Fund grant to develop a strategy for better follow-up of First Nations children after they’ve been hospitalised for respiratory infections, in a bid to halt the slide into more severe lung disease.

News & Events

Two outstanding researchers from the Wal-yan Respiratory Research Centre have been awarded Vertex Cystic Fibrosis (CF) Mentored Innovation Research Awards.